The market size of Sarcopenia is expected to increase at a significant CAGR during the study period (2017–2030). Among all the seven major markets, the United States accounted for the largest Sarcopenia market size. Among EU5 countries, Italy had the highest market size, with USD 115.87 million in 2017, while Spain had the lowest market size of Sarcopenia, with USD 54.33 million in 2017.
top of page
bottom of page